The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,332.00
Bid: 11,500.00
Ask: 12,400.00
Change: 0.00 (0.00%)
Spread: 900.00 (7.826%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Astra's Covid-19 Vaccine Authorised In UK

Wed, 30th Dec 2020 07:49

(Alliance News) - London stock prices are set for a marginally higher open on Wednesday, as the post-Brexit trade deal moves toward implementation and the first jabs of the AstraZeneca vaccine are set to begin early in the New Year.

AstraZeneca said its Covid-19 vaccine has been authorised for emergency supply in the UK.

In other early company news, Energean reported an up to USD405 million purchase of the remaining stake in its Israel unit.

IG says futures indicate the FTSE 100 index of large-caps to open 9.65 points, or 0.2%, higher at 6,612.30 on Wednesday. The FTSE 100 closed up 100.54 points, or 1.6%, at 6,602.65 on Tuesday.

Sterling was quoted at USD1.3550 early Wednesday, rallying from USD1.3509 at the London equities close on Tuesday.

UK house prices surged in December to post their fastest growth in six years, according to the house price index from mortgage lender Nationwide on Wednesday.

House prices jumped 7.3% year-on-year in December, accelerating from rises of 6.5% in November and 5.8% in October to achieve the highest annual growth rate since 2014.

Month-on-month, house prices rose 0.8%, a touch slower than the 0.9% growth seen in November.

The average UK house price stood at GBP230,920 in December versus GBP229,721 in November.

House prices ended the year 5.3% above the level prevailing in March, when the pandemic struck the UK.

The euro traded at USD1.2284 early Wednesday, firming from USD1.2246 late Tuesday.

The UK and EU will on Wednesday sign a mammoth trade pact to put the seal on their drawn-out Brexit divorce in the dwindling hours before they part ways definitively at the dawning of 2021.

EU chiefs Ursula von der Leyen and Charles Michel will ink the 1,246-page Trade & Cooperation Agreement at 0830 GMT, officials in Brussels said, days after it was clinched on Christmas Eve following months of hard-fought talks.

The hefty document will then be flown by the Royal Air Force to London for UK Prime Minister Boris Johnson to add his signature, as the UK parliament embarks on a rushed debate to clear the decks before a December 31 deadline.

According to Downing Street, Johnson will tell MPs that the agreement heralds "a new relationship between Britain and the EU as sovereign equals, joined by friendship, commerce, history, interests and values".

The government only released the accompanying UK legislation on Tuesday afternoon – less than 24 hours before the debate is to start in Parliament an hour after the signing in Brussels.

AstraZeneca said its Covid-19 vaccine has been approved for emergency supply in the UK, with the first doses being released on Wednesday so that vaccinations may begin early in the New Year.

The healthcare company said it aims to supply millions of doses in the first quarter as part of an agreement with the UK government to supply up to 100 million doses in total.

The vaccine was authorised by the UK Medicines & Healthcare Products Regulatory Agency, recommending two doses administered with an interval of between four and 12 weeks. Clinical trials showed the vaccine to be safe and effective at preventing symptomatic Covid-19, with no severe cases and no hospitalisations more than 14 days after the second dose.

Energean said it has agreed with Kerogen Investments, an affiliate of Kerogen Capital, for the acquisition of Kerogen's 30% shareholding in Energean Israel, which would result in Energean owning 100% of Israel unit share capital.

A total consideration of between USD380 million and USD405 million, the gas exploration and production company said.

Energean said the acquisition adds 2P reserves of 29.5 billion cubic metres of gas and 30 million barrels of liquids, representing 219 million barrels of oil equivalent in total, to the company.

Taking a 100% interest in Energean Israel will enable Energean to fully control its capital structure, it said, enhancing its ability to maximise total shareholder returns.

Exploration and development company Indus Gas reported a decline in pretax profit for the six months to the end of September to USD20.9 million from USD26.1 million a year earlier, as adjusted revenue declined to USD23.2 million from USD27.7 million.

The company said its administrative expenses rose to USD586,360 from USD303,970 year-on-year.

"While the pandemic has presented unprecedented operational challenges, the company remains focused on executing our strategy to maximize value for all of our stakeholders," said Chair Peter Cockburn.

In the US on Tuesday, Wall Street ended lower, with the Dow Jones Industrial Average and the S&P 500 both ending down 0.2% and the Nasdaq Composite down 0.4%.

In Asia on Wednesday, the Japanese Nikkei 225 index closed down 0.5%. Against the yen, the dollar was quoted at JPY103.31, slightly down from JPY103.51.

"The US dollar continued to beat a modest retreat overnight, weakening across the board versus G-10 and Asian currencies," noted Halley.

In China, the Shanghai Composite closed up 1.1%, while the Hang Seng index in Hong Kong was up 1.9%. The S&P/ASX 200 in Sydney closed down 0.3%.

"Asia has a pre-New Year's Eve look about it today, as an empty data calendar combined with an ever-present headline risk leaves the region's financial markets content to drift on the currents," said Halley.

Gold was quoted at USD1,880.65 an ounce early Wednesday, slightly lower than USD1,882.29 on Tuesday. Brent oil was trading at USD51.44 a barrel early Wednesday, firm from USD51.16 late Tuesday.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.